Sanofi gets EMA panel recommendation for Dupixent to treat eosinophilic esophagitis Ruchika Sharma19 Dec 2022 10:30 AM ISTEoE is a chronic, progressive inflammatory disease that damages the esophagus and prevents it from working properly.
Sanofi Dupixent gets European Commission nod for Prurigo Nodularis Ruchika Sharma18 Dec 2022 5:30 PM ISTParis: Regeneron Pharmaceuticals, Inc. and Sanofi have announced that the European Commission (EC) has expanded the marketing authorization for...
After Sanofi drops out of Horizon bid, Amgen emerges as frontrunner Ruchika Sharma12 Dec 2022 1:30 PM ISTSanofi said on Sunday that it was no longer in discussions with Horizon and does not intend to make an offer for it.
Cancer Litigation over Zantac: US Court gives relief to pharma cos, dismisses thousands of lawsuits Ruchika Sharma7 Dec 2022 1:10 PM ISTA Sanofi spokesperson said the decision "significantly decreases the scope of the litigation potentially by over 50%," with the remaining litigation...
Sanofi, JnJ, Amgen in talks to acquire Horizon Therapeutics Ruchika Sharma1 Dec 2022 4:33 PM ISTBengaluru: Horizon Therapeutics Plc said on Tuesday its board was engaged in highly preliminary discussions with three pharmaceutical giants for...
Britain regulator calls for review of reactions in eyes to Sanofi asthma drug Dupixent Ruchika Sharma30 Nov 2022 5:30 PM ISTEuropean and U.S. health regulators have listed conjunctivitis, an eye irritation that can cause redness and discomfort, as a side effect of Dupixent
Tzield, the World's First USFDA approved drug to delay type 1 diabetes onset to cost more than Rs 11 lakh per vial, confirm makers Ruchika Sharma19 Nov 2022 11:49 AM ISTNew Jersey: With the recent USFDA, approval of the first drug to delay type 1 diabetes onset, teplizumab, makers of the drug Provention Bio...
Sanofi Dupixent recommended for EU approval by CHMP for prurigo nodularis treatment Ruchika Sharma13 Nov 2022 4:30 PM ISTDupixent is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways and is not...
Former Sanofi head Christopher A Viehbacher appointed as Biogen new President, CEO Ruchika Sharma11 Nov 2022 12:30 PM ISTCambridge: Biogen Inc. has announced that its Board of Directors has appointed Christopher A. Viehbacher as President and Chief Executive Officer and...
Sanofi gets CDSCO panel nod to market Biphasic Insulin Aspart Injection Dr. Divya Colin8 Nov 2022 6:00 PM ISTNew Delhi: With a condition of conducting a phase IV study, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Sanofi gets European Commission nod for Beyfortus to prevent RSV disease in infants Ruchika Sharma5 Nov 2022 3:00 PM ISTRSV is the most common cause of LRTI, including bronchiolitis and pneumonia, in infants.
Sanofi forecasts faster profit growth on Dupixent, flu vaccine demand Ruchika Sharma30 Oct 2022 10:00 AM ISTParis: French drugmaker Sanofi on Friday forecasted faster earnings growth this year on strong demand for its bestselling drug Dupixent and for...
